Home500660 • BOM
add
GlaxoSmithKline Pharmaceuticals Limited
Previous close
₹2,453.35
Day range
₹2,427.95 - ₹2,486.20
Year range
₹1,472.65 - ₹3,087.95
Market cap
413.37B INR
Avg Volume
3.96K
P/E ratio
61.98
Dividend yield
1.30%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 10.11B | 5.62% |
Operating expense | 3.21B | -2.94% |
Net income | 2.52B | 16.09% |
Net profit margin | 24.98 | 9.90% |
Earnings per share | — | — |
EBITDA | 3.21B | 11.39% |
Effective tax rate | 26.56% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.11B | 31.49% |
Total assets | 37.46B | 14.55% |
Total liabilities | 20.73B | 19.80% |
Total equity | 16.73B | — |
Shares outstanding | 172.12M | — |
Price to book | 25.25 | — |
Return on assets | — | — |
Return on capital | 43.75% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 2.52B | 16.09% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
Founded
Nov 13, 1924
Website
Employees
3,211
